Showing 481 - 500 results of 34,508 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 100 ((mean decrease) OR (we decrease)) ))', query time: 0.98s Refine Results
  1. 481

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…Untreated controls showed no differences at any time, and are combined as a single group in each graph (N = 23). Maximum actomyosin MgATPase activity tended to decrease following PPT treatment, but did not reach statistical significance. …”
  2. 482
  3. 483
  4. 484
  5. 485

    Summary of the gradual disappearance of the peaks with decreasing DMSO-d6 concentrations. by Swagata Chakraborty (188090)

    Published 2012
    “…<p>(<b>A</b>) <sup>1</sup>H-<sup>15</sup>N HSQC spectra of GED in 100%, 90%, 85%, 80%, 70% and 50% DMSO-d6 at 45°C, as marked in the left hand panel within the spectra. …”
  6. 486
  7. 487

    Loss of Trib2 decreases disease latency of Notch-driven T-ALL. by Sarah J. Stein (3168600)

    Published 2016
    “…Mice with a body condition score of ≤2 and decreased mobility were euthanized (n = 8 Trib2<sup>+/+</sup> and n = 12 Trib2<sup>-/-</sup> recipients. …”
  8. 488
  9. 489
  10. 490
  11. 491
  12. 492
  13. 493
  14. 494
  15. 495
  16. 496
  17. 497
  18. 498

    Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

    Published 2010
    “…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”
  19. 499
  20. 500